iPACK block with adductor canal block vs. lumbar erector spinae plane block (L-ESPB) in total knee arthroplasty: a randomized, double-blinded, controlled trial
Anaesthesiology Intensive Therapy · 21.08.2025 · 57 (1) · 195-204
DOI: 10.5114/ait/208016 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Anaesthesiology Intensive Therapy, online erschienen am 21.08.2025. Verfasst von Tomasz Reysner und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Palliative Medicine, Poznań University of Medical Sciences, Poznań, Poland. Hauptthemen laut MEDLINE: Nerve Block, Arthroplasty, Replacement, Knee, Postoperative Pain. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Introduction
Total knee arthroplasty (TKA) is associated with severe pain. We examined whether an ultrasound-guided, single-injection L2 erector spinae plane block could improve analgesia compared to an ultrasound-guided iPACK (infiltration between the popliteal artery and capsule of the knee) block with adductor canal block (ACB) in patients undergoing TKA under spinal anesthesia. Material and methods Ninety patients aged 65–89 years of both sexes (ASA I–III) scheduled for TKA were randomly allocated to receive iPACK block (ropivacaine 0.2%, 20 mL) with ACB (ropivacaine 0.2%, 10 mL), lumbar erector spinae plane block (L-ESPB) (ropivacaine 0.2%, 20 mL on each side), or to the control group. The primary outcome was total opioid consumption. The secondary outcomes included pain scores, time to first rescue opioid analgesia, quadriceps muscle strength, neutrophil-to-lymphocyte ratio (NLR), and platelet- to-lymphocyte ratio (PLR).
Results
The total opioid consumption in 48 h was significantly lower in the iPACK+ACB group (mean ± SD) (3.0 ± 3.3) compared to L-ESPB (6.8 ± 3.8, P = 0.0442) and the control group (18.2 ± 4.0, P < 0.001). The time to first rescue opioid analgesia was longer in the iPACK+ACB (12.0 ± 1.9) compared to the L-ESPB (9.2 ± 1.9, P < 0.001) group and the control group (4.3 ± 1.1, P < 0.001). The pain scores, NLR, and PLR levels were significantly lower in the iPACK+ACB and L-ESPB groups than at all time points in the control group.
Conclusions
The iPACK+ACB is more effective than L-ESPB in pain management following TKA. iPACK+ACB and the L-ESPB lowered total opioid consumption and prolonged time to first opioid analgesia. NLR and PLR levels did not differ between the groups.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Palliative Medicine, Poznań University of Medical Sciences, Poznań, Poland.
- Department of Orthopedics, Poznań University of Medical Sciences, Poznań, Poland.
- Department of Organization and Management in Health Care, Poznań University of Medical Sciences, Poznań, Poland.
Zitieren
APA
Reysner, T., Wieczorowska-Tobis, K., Kowalski, G., Lapaj, L., Daroszewski, P., & Reysner, M. (2025). iPACK block with adductor canal block vs. lumbar erector spinae plane block (L-ESPB) in total knee arthroplasty: a randomized, double-blinded, controlled trial. Anaesthesiology Intensive Therapy, 57(1), 195-204. https://doi.org/10.5114/ait/208016
Vancouver
Reysner T, Wieczorowska-Tobis K, Kowalski G, Lapaj L, Daroszewski P, Reysner M. iPACK block with adductor canal block vs. lumbar erector spinae plane block (L-ESPB) in total knee arthroplasty: a randomized, double-blinded, controlled trial. Anaesthesiology Intensive Therapy. 2025;57(1):195-204. doi:10.5114/ait/208016
BibTeX
@article{Reysner2025,
author = {Reysner, Tomasz and Wieczorowska-Tobis, Katarzyna and Kowalski, Grzegorz and Lapaj, Lukasz and Daroszewski, Przemyslaw and Reysner, Małgorzata},
title = {iPACK block with adductor canal block vs. lumbar erector spinae plane block (L-ESPB) in total knee arthroplasty: a randomized, double-blinded, controlled trial},
journal = {Anaesthesiology Intensive Therapy},
year = {2025},
volume = {57},
number = {1},
pages = {195--204},
doi = {10.5114/ait/208016}
}
EUVIMED